DRIVIN G ROWTH - Dr. Reddy's

136
balance sheet abstract and company’s general business profile
1. Registration Details
Registration No. : 4 5 0 7 State Code : 0 1
Balance Sheet Date : 3 1 0 3 0 2
Date Month Year
2. Capital Raised during the year (Amount in Rs. thousands)
Public Issue : N I L Rights Issue : N I L
Bonus Issue : N I L Private Placement* : 6 6 6 9 2*
*Shares issued pursuant to merger of American Remedies Ltd. with the Company and issue of American Depository Shares.
3. Position of Mobilisation and Deployment of Funds (Amount in Rs. thousands)
Total Liabilities : 1 4 7 1 8 0 7 4 Total Assets : 1 4 7 1 8 0 7 4
Sources of Funds:
Paid-up Capital : 3 8 2 5 8 0 Reserves and surplus : 1 4 1 9 7 2 9 4
Secured Loans : 5 3 0 1 4 Unsecured loans : 8 5 1 8 6
Application of Funds:
Net Fixed Assets : 3 9 5 9 6 4 7 Investments : 6 3 9 4 3 2
Net Current Assets : 1 0 5 5 3 9 6 8 Miscellaneous Exp. : N I L
4. Performance of the Company (Amount in Rs. thousands)
Turnover : 1 6 5 1 6 3 4 7 Total Expenditure : 1 1 8 0 8 6 1 9
Profit Before Tax : 4 7 0 7 7 2 8 Profit After Tax : 4 5 9 6 5 0 5
Earnings per Share in Rs : 6 0 . 4 1 Dividend % : 1 5 0
5. Generic Names of Three Principal Products/Services of Company (as per monetary terms)
Item Code No.
(ITC Code)
: 2 9 4 1 9 0 0 3
Product Description : CIPROFLOXACIN HYDROCHLORIDE
Item Code No.
(ITC Code)
: 2 9 4 2 0 0 0 1
Product Description : NORFLOXACIN
Item Code No.
(ITC Code)
: 3 0 0 4 9 0 3 8
Product Description : OMERPRAZOLE
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002